Skip to main content

Table 1 Clinical characteristics of the cohort

From: Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury

Characteristics of the cohort

Values

n

Age (years)

39 (25–55)

49

Height (m)

1.75 (1.70–1.80)

29

Weight (kg)

70 (66–80)

31

GCS on scene

7.0 (3.0–10.0)

49

Abnormal pupil reaction on scene

18/45 (40.0%)

45

Alcohol smell

15/46 (32.6%)

46

Intubation on scene

38/49 (77.6%)

49

GCS in emergency department

3.0 (3.0 – 3.0)

46

Abnormal pupil reaction in emergency department

18/46 (39.1%)

46

SAPS II

52.0 (44.5–56.5)

39

ISS

29 (25–34)

49

Mortality at 14 days

11/49 (22.4%)

49

GCS at 14 days

11.0 (3.0–15.0)

49

GCS of survivors at 14 days

13.5 (8.0–15.0)

38

Abnormal pupil reaction of survivors at 14 days

4/34 (11.8%)

34

Mortality at 3 months

15/49 (30.6%)

49

GOSE at 3 months

3.0 (1.0–4.0)

37

GOSE of survivors at 3 months

3.5 (3.0–4.0)

22

LOS of survivors in ICU (days)

9.0 (4.0–15.0)

37

LOS of survivors in acute hospital (days)

15.5 (10.0–24.5)

36